The performance question

Athletes are taught to pay attention to everything that shapes performance: training load, sleep, recovery, hydration, macros, supplements. Because small variables matter, especially when repeated over time.

Plastic is still rarely treated that way. It tends to sit outside the performance conversation, folded into daily habit and dismissed as part of the environment.

That assumption is becoming harder to defend.

Microplastics and nanoplastics reach the body primarily through inhalation and ingestion, with contact-associated routes and plastic-linked chemical exposures adding further complexity ^[1-6]. Training changes the interface between body and environment. It increases ventilation, raises fluid intake, expands time spent on synthetic surfaces, and intensifies contact with synthetic apparel, equipment, and indoor training spaces ^[1-6].

One point has to stay clear from the start: no published human study directly shows that routine environmental microplastic exposure lowers VO₂max, sprint power, endurance, or strength in human athletes ^[4,5,53]. The field is rich in mechanism and still sparse in direct sports-performance endpoints.

That does not make the question weak. It makes it early. Across the literature, the same systems appear again and again: mitochondrial energetics, fuel handling, anabolic signaling, vascular function, pulmonary integrity, endocrine balance, gut barrier biology, oxidative stress, and inflammation ^[3-5,12-51]. For athletes, those are not side systems. They are the machinery of recovery and performance.

What the literature says (and what it doesn’t)

The literature on microplastics and athletic performance is no longer empty. But it is still uneven.

What exists today is a layered body of evidence. At the outer edge are exposure studies, athlete-focused reviews, and environmental measurements showing that athletes may encounter microplastics through air, water, sports surfaces, supplements, apparel, and indoor training spaces ^[5-14].

Deeper in are human tissue-detection and clinical papers showing that microplastics and nanoplastics, or related plastic-associated signals, are being identified in human plaques, reproductive tissues, and other biological samples ^{[25-35,46,47,53]}. And underneath that is the mechanistic core: animal and in vitro studies describing effects on mitochondria, skeletal muscle, vascular biology, pulmonary tissue, endocrine signaling, gut barrier function, oxidative stress, and inflammation ^{[15-24,36-52,54-56]}.

That is enough to justify a serious question. It is not enough to claim a settled answer.

No study in the current source set directly demonstrates that routine environmental microplastic exposure measurably lowers endurance, strength, sprint capacity, or recovery in human athletes ^[5,6,53]. There are no prospective athlete cohorts linking body burden to performance outcomes. There are no controlled exercise trials showing that athletes exposed to higher environmental plastic loads adapt more poorly over time. There is no clinical threshold that tells us how much exposure begins to matter, in which tissue, or under what training conditions ^[5,6,53].

So the right reading of the field is neither dismissive nor overstated.

The literature does not currently show that microplastics are a proven cause of impaired athletic performance in humans. But it does show that athletes move through a distinctive exposure landscape, that internal exposure is biologically real, and that the systems most consistently implicated in the mechanistic literature are the same systems that support performance: mitochondrial function, fuel handling, oxygen delivery, endocrine balance, barrier integrity, and recovery biology ^{[3-6,15-24,36-56]}.

In other words, the field has not answered the performance question. But it has made the question legitimate.

A deeper review, then, has to hold two ideas at once. First, the evidence is still early, indirect, and heavily preclinical. Second, the pattern across that evidence is now coherent enough that it can no longer be waved away as speculative background noise ^{[3-6,25-35,36-56]}.

The athletic body as a different kind of filter

Athletes are not automatically the highest-burden population, and the literature does not support a simple multiplier suggesting they retain a fixed several-fold greater plastic load than everyone else. That stronger claim still lacks direct biomonitoring support. But athletes do live inside a distinct exposure context.

Training changes the interface between body and environment. Ventilation rises sharply with effort, fluid intake increases, blood flow patterns shift across the gut and skin, and contact with synthetic surfaces, apparel, and equipment becomes more frequent and more sustained. Minute ventilation can rise from roughly 6 to 8 L/min at rest to 80 to 120 L/min during vigorous exercise, and up to 150 to 200 L/min at maximal effort in elite athletes, representing a 10- to 25-fold increase in air processed through the respiratory tract ^[4,5]. At those flow rates, mouth breathing becomes more common, bypassing part of the filtration normally provided by the nose and increasing the likelihood that airborne particles reach deeper into the lung ^[57,58]. In practical terms, training changes both how much of the outside world moves through the body and how the body receives it ^[5,6].

That is why Kistler’s epithelial barrier framework is so useful here ^[6]. It resists the urge to treat microplastics as an isolated threat and instead places them inside a broader athlete physiology. Athletes already stress the respiratory tract, gastrointestinal tract, and skin through heat, dehydration, repeated exertion, travel, altered food environments, and regular contact with pollutants and synthetic materials. Microplastics sit within that larger barrier story. The relevant question is not whether they are uniquely catastrophic. It is whether they add friction to systems athletes rely on to adapt, recover, and remain resilient.

Jiao’s review helps build the exercise-science bridge ^[5]. Athletes do not encounter exposure in the abstract. They encounter it under conditions of elevated airflow, high fluid turnover, repeated contact with synthetic environments, and heightened physiological demand. A small disturbance in airway inflammation, glucose handling, or endocrine stability may be hard to detect in a sedentary population. In an athlete trying to hold threshold work, recover between sessions, or maintain stable adaptation across a season, the same disturbance may matter more.

Every surface, every sip: The athlete’s exposure landscape

The clearest evidence in this field is still about opportunity for exposure. That may sound modest. It is not. When exposure routes repeat daily, across air, water, surfaces, food, and gear, opportunity becomes the substrate on which biology accumulates.

Supplementation and sports nutrition

One of the more concrete athlete-specific routes is supplementation. Chen and colleagues detected microplastics in all 30 sports protein supplements they analyzed, with 2 to 19 particles per 30 gram serving and a modeled hazard profile that became more concerning under high-use scenarios ^[8]. Plant-derived products also carried higher levels of lead and cadmium, raising the possibility of combined exposure rather than a single-pollutant story. This is where the so-called Trojan horse idea becomes relevant: particles may not act alone, but as carriers for metals and other contaminants ^[8].

That does not mean protein powders are uniquely dangerous. It means a product category deeply normalized in athletic culture has now been analytically confirmed as one plausible route of repeated exposure. For athletes taking one to three servings per day, that route becomes routine, cumulative, and easy to overlook if attention stays fixed on bottles and food packaging.

Milne and colleagues extend the picture beyond supplementation alone, reporting a mean of 74 microplastic particles per serving across commonly consumed protein products ^[59]. The point is not that athletes should fear protein. The point is that sports nutrition sits inside a broader food-contact and packaging ecosystem, and repeated use changes dose opportunity.

Synthetic sports surfaces

The sports environment itself is another meaningful source. Fu’s review makes the case that synthetic sports surfaces are not inert from an air-quality standpoint ^[9]. Savva sharpens that point by identifying inhalable plastic-related material and 56 additives associated with crumb-rubber systems, including plasticizers, pigments, UV filters, flame retardants, and metal ions, with airborne concentrations reaching up to 30,426 ng/m3 ^[10]. Ferreira adds evidence that downcycled tire microplastics on synthetic football fields can also carry volatile methylsiloxanes ^[11]. Hua and Zhang extend the story further, showing that synthetic fields and their runoff do not simply hold particles in place. They generate, weather, and distribute them, sometimes alongside adsorbed heavy metals or other co-pollutants ^[12,13].

Grynkiewicz-Bylina and colleagues add another layer, reporting carcinogenic PAHs in rubber granules used on artificial turf at concentrations ranging from 0.86 to 172 mg/kg ^[60]. That matters because athletes do not train in a chemically neutral setting. A football pitch, track, indoor turf facility, or gym floor is not just a backdrop for movement. It is part of the exposure system. Abrasion, impact, heat, UV exposure, weathering, and maintenance practices may all shape what gets released into the air, dust, runoff, or onto the skin ^[9-13,60].

Indoor environments

Indoor environments deserve more attention than they usually receive. Salthammer’s review is not sports-specific, but its relevance to gyms, studios, training rooms, and indoor tracks is obvious ^[7]. Spaces rich in synthetic flooring, textiles, furnishings, foam equipment, and recurring abrasion can become microplastic reservoirs. In a high-ventilation context, that background becomes more relevant.

A runner moving large volumes of air through the respiratory tract during interval work, or a lifter spending hours each week in a textile-heavy gym, does not interact with the same exposure profile as someone entering that space briefly and at rest. Indoor exposure is easy to underestimate precisely because it feels familiar. But repeated training in enclosed synthetic environments may turn ordinary background contamination into a meaningful part of the athlete’s cumulative exposure pattern ^[7].

Water and beverages

Water is not an athlete-only issue, but athletic behavior changes dose opportunity. Athletes often drink more, drink more often, and drink under conditions of heat stress. That makes background contamination more relevant. Bottled water studies have reported average concentrations around 325 microplastic particles per liter, with some samples far higher ^[61]. The routine mechanics of packaging may matter too. Opening and closing plastic containers can generate additional particles with each cycle, an observation that has obvious relevance for squeeze bottles, shaker bottles, and single-serve sports packaging ^[62].

Sports drinks, gels, packaged recovery products, and convenience foods add further routes. None of these exposures are unique to athletes. What changes is frequency. High-volume consumption turns a background route into a repeated one. The literature still does not offer a clean athlete-versus-control biomonitoring study showing how much of this translates into retained body burden. But it does support the simpler and more important point: athletes often live inside a more exposure-dense daily routine ^[5,6,8].

Dermal exposure

Dermal exposure is the most uncertain route for intact particles, but not for associated chemicals. Sweat, friction, and heat make that distinction more important, not less. Tight synthetic apparel, repeated motion, and prolonged contact with performance fabrics create a plausible pathway for plastic-associated chemicals even where penetration of intact particles remains much less certain.

The Center for Environmental Health reported that sports bras and athletic shirts from major brands contained BPA at levels up to 40 times the California Proposition 65 safe limit, with transfer concerns heightened under warm, sweaty conditions typical of exercise ^[63]. Research on sweat-induced aggregation of nanoplastics further suggests that perspiration changes particle behavior at the skin surface, which may alter dermal penetration risk in ways that are both body-region-specific and material-specific ^[64]. Separate work has shown that wet or sweaty skin can absorb substantially more BPA than dry skin ^[65].

This is one reason the endocrine section has to be handled with care. In real life, exposure is rarely a clean single-agent event. It is often a mixture of particles, additives, packaging residues, synthetic fibers, sweat, and repeated contact with surfaces. That complexity does not weaken the concern. It clarifies what kind of concern it is ^{[6,10,11,43-47,56,63-65]}.

The engine room: What microplastics do to muscle and metabolism

If this question is going to sharpen anywhere first, it is likely to sharpen in muscle.

That is partly because skeletal muscle is the obvious tissue of performance. But it is also because muscle is one of the body’s central metabolic organs. It handles most insulin-stimulated glucose disposal, consumes large amounts of ATP during both work and recovery, and depends on tight coordination between mitochondrial function, anabolic signaling, and regenerative capacity. That makes it a plausible site where low-grade environmental stress could matter before anyone sees a clear clinical endpoint. The muscle literature is not yet sports-performance science. But it is increasingly coherent, and the direction of concern is not random ^[36-42].

Mitochondrial function and fuel handling

One of the clearest entry points into the problem is mitochondrial stress.

Tang and colleagues showed that polystyrene particles impaired insulin-stimulated glucose uptake in skeletal muscle cells while increasing mitochondrial reactive oxygen species and disrupting mitochondrial function ^[36]. That matters because it places the insult directly at the interface between fuel handling and energy production. In performance terms, mitochondria are not background machinery. They are the system that determines how efficiently substrate can be turned into usable work. If glucose uptake worsens while mitochondrial stress rises, the relevant downstream questions are immediate: what happens to glycogen restoration, repeated high-intensity efforts, metabolic flexibility, or day-to-day training quality under persistent low-level stress?

The mechanistic detail strengthens the point. MitoQ, a mitochondria-targeted antioxidant, partly rescued the observed defects, which suggests that mitochondrial ROS is not just present in the model but functionally upstream of the dysfunction itself ^[36]. That makes the paper more informative than a generic toxicity study. It identifies a plausible driver.

Bang and colleagues extend that story in pre-differentiated skeletal myoblasts ^[66]. In their work, polystyrene nanoplastics induced mitochondrial membrane depolarization, structural fragmentation, reduced ATP production, and elevated superoxide. But the paper also pushes beyond acute injury. These changes were accompanied by premature cellular senescence, including increased beta-galactosidase activity and upregulation of p16 and p21, suggesting that nanoplastics may not simply damage muscle cells in the moment. They may shift them into an older, less resilient biological state. The ROS scavenger Mito-TEMPO attenuated that phenotype, again pointing back to oxidative stress as a central mechanism ^[66].

That combination matters. It suggests the issue may not be only reduced power production in the short term. It may also involve a slower decline in tissue quality, repair efficiency, and metabolic responsiveness over time.

Tissue-level energy metabolism

The next question is whether these cellular signals persist at the tissue level. Chakraborty and Pal suggest that they do ^[37].

In rats, sub-acute polystyrene microplastic exposure disrupted glycogen status, pyruvate availability, glycolytic enzymes, and TCA-linked energy pathways while also damaging muscle architecture. Muscle glycogen fell in a dose-dependent way, with reported reductions in the range of 15 to 30%, alongside increased protein oxidation and protease activity ^[37]. That pattern does not read like a single isolated injury. It reads like a shift in the metabolic environment of muscle.

For athletes, that distinction matters. A muscle that stores less glycogen, handles pyruvate less efficiently, and shows disrupted glycolytic and mitochondrial enzyme activity is not just “damaged.” It may become less metabolically flexible. In practice, that could mean less efficient substrate use, more fatigue at a given workload, or a narrower margin for adaptation under repeated training stress. None of that has been demonstrated directly in human athletes. But the metabolic direction of effect is increasingly hard to ignore.

This is also where the literature starts to feel more relevant to performance than a simple muscle-loss narrative. Athletes do not need frank wasting for performance biology to be disrupted. A modest decline in metabolic efficiency, repeated often enough, may matter sooner than overt atrophy.

Anabolic signaling

Choi’s 2026 atrophy paper helps consolidate the next layer of concern by linking polystyrene microplastic exposure to disruption of anabolic signaling and mitochondrial function in skeletal muscle ^[39].

The reason this matters is straightforward. The IGF-1/PI3K/Akt/mTOR axis is one of the central pathways through which nutrition, training, and hormonal state support lean mass maintenance, repair, and adaptation. If that axis is suppressed while proteolytic and stress pathways rise, the tissue environment begins to tilt away from growth and toward breakdown. In Choi’s model, that shift was accompanied by higher atrogin-1 and MuRF1 expression and activation of FoxO3a, a pattern that points toward ubiquitin-proteasome mediated catabolism ^[39].

That is not a trivial signal. It means the literature is no longer merely suggesting that microplastics can “stress” muscle. It is identifying pathways through which the balance between synthesis and degradation may be pushed in the wrong direction.

Earlier murine work showed this general pattern translating into measurable decreases in skeletal muscle mass and grip strength after oral microplastic administration ^[67]. That does not settle the human question. But it does show that the shift is not purely molecular window dressing. Under at least some experimental conditions, it reaches whole-animal function.

The relevant athletic takeaway is not that microplastics have been proven to make athletes weaker. It is that the major signaling architecture supporting hypertrophy, maintenance, and adaptation now sits plausibly inside the exposure story.

Regeneration and satellite cell fate

The regeneration literature may be even more important than the atrophy literature.

Wang’s findings move the discussion beyond acute injury and into the biology of repeated repair ^[38]. Skeletal muscle performance depends not only on what happens during a session, but on what happens in the hours and days after it, when tissue has to rebuild in the right direction. In Wang’s model, oxidative and inflammatory signaling pushed satellite cells away from myogenesis and toward adipogenic differentiation. In simpler terms, the biology of repair was nudged away from muscle formation and toward fat formation ^[38].

That changes the frame considerably. The concern is no longer only that muscle may be damaged. It is that the quality of adaptation itself may become less reliable.

Mechanistically, the pathway ran through ROS-driven NF-kB signaling, and N-acetylcysteine alleviated some of the observed effects, which again places oxidative stress upstream rather than incidental ^[38]. This matters because athletes do not improve because one training session goes well. They improve because tissue repeatedly repairs in a coordinated way across hundreds of sessions. A pollutant that subtly distorts that regenerative logic could matter long before obvious weakness or tissue loss appears.

In that sense, regeneration may be one of the most performance-relevant parts of the whole muscle literature. It connects microplastic exposure not just to injury, but to the quality of adaptation over time.

Broader musculoskeletal context

The broader musculoskeletal reviews help show that this is no longer a one-paper concern.

Purcaro places skeletal muscle within the wider exposome framework, which is useful because it reminds us that muscle is constantly responding not only to exercise and nutrition, but also to environmental inputs ^[40]. Fusagawa and Zhao widen the lens further, arguing that microplastics may have implications across musculoskeletal and skeletal biology more broadly ^[41,42]. These reviews do not solve the translational problem. But they do show that muscle is no longer a speculative side note in the literature. It has become one of the main tissues through which concern is being organized.

The recent detection of microplastics in human skeletal muscle and bone tissue adds another important shift ^[68]. Detection does not prove dysfunction. But it does establish access. These particles are not simply theoretical visitors to the musculoskeletal system. They can reach it.

That matters because it removes an older, more comfortable assumption that muscle concerns are only downstream or indirect. At least some part of the literature now supports the idea that musculoskeletal tissue may be a direct compartment of exposure.

A more subtle point deserves emphasis here. In athletic physiology, dysfunction does not have to announce itself first as dramatic weakness or obvious wasting. It may appear earlier as less efficient glucose handling, noisier oxidative metabolism, more fatigue at a given workload, slower restoration after hard sessions, or a less stable response to training. That is why the muscle literature matters even before human performance studies exist. It is mapping the metabolic terrain on which performance is built ^[36-42].

Heart, lungs, and blood vessels: The oxygen delivery problem

If muscle is the engine, the cardiopulmonary system is the delivery network that keeps it running. Oxygen has to move from air to alveoli, across the lung barrier, into blood, through the vasculature, and finally into working tissue. Performance depends on the integrity of that entire chain. That is why the heart, lungs, and blood vessels deserve their own section in this literature.

The cardiopulmonary evidence is also where mechanistic seriousness and translational restraint need to stay in the same paragraph. The mechanistic signal is substantial. The leap to athletic performance is still not licensed. Animal and cell work now suggests multiple routes by which microplastics and nanoplastics could interfere with oxygen delivery, vascular responsiveness, or pulmonary resilience. But those routes remain mostly inferential when the subject is a healthy athlete ^[15-24,54].

Cardiac effects

The cardiac literature points in a consistent direction: oxidative stress rises, mitochondrial function worsens, inflammatory signaling increases, and tissue-level injury follows.

Kehinde describes cardiopulmonary disruption in rats exposed to polyethylene microplastics through a linked pattern of oxidative stress, inflammatory crosstalk, and mitochondrial dysfunction ^[15]. Mohamed reports elevations in CK-MB, LDH, CPK, and cardiac troponin I after 60 days of polystyrene exposure in mice, alongside histologic injury in both heart and lung tissue ^[16]. Those markers are familiar because they sit close to the language of exercise physiology and cardiology. They do not mean microplastic exposure reproduces exercise-induced cardiac stress. They do suggest that exposure can push the heart toward a more damaged biochemical state.

Huang deepens that concern by linking inhaled polystyrene microplastics to myocardial fibrosis through a ferroptosis pathway involving HIF-1α upregulation, oxidative stress, and suppression of SLC7A11 and GPX4 ^[17]. Echocardiography in the exposed mice showed impaired systolic and diastolic function, which is important because it moves the story beyond molecular markers and into organ-level performance. Liang adds a related layer, showing cardiac injury aggravated through mitochondrial dynamics disorder and ferroptosis, alongside metabolic disruption in cAMP signaling, the TCA cycle, and tryptophan metabolism ^[18].

None of these are athlete studies, and none justify the claim that microplastics have been shown to reduce cardiac performance in trained humans. But together they outline a biologically coherent concern. If microplastics raise oxidative load, impair mitochondrial handling, and alter the cardiac microenvironment, then the tissue responsible for maintaining output under stress is no longer comfortably outside the exposure story ^[15-18].

Vascular endothelial function

The vascular literature may be even closer to performance physiology than the cardiac literature, because blood flow regulation is so central to exercise.

Cary is especially important here because endothelial function sits right at the intersection of perfusion and performance ^[19]. Nitric oxide signaling is one of the main ways blood vessels dilate in response to demand. In a rat inhalation model of gestational exposure, micro and nanoplastic inhalation reduced activated eNOS by more than 50% in uterine vasculature, led to BH4 deficiency, increased nitrosative stress, and caused eNOS uncoupling, a state in which the enzyme shifts from producing protective nitric oxide to producing damaging superoxide ^[19].

The model is pregnancy-specific, and that limitation matters. But the endothelial mechanisms do not belong only to pregnancy. eNOS uncoupling, BH4 depletion, and nitrosative stress are shared vascular problems. That makes the paper relevant beyond its immediate context. If inhaled micro and nanoplastics can blunt endothelial-dependent dilation through nitric-oxide disruption, then one of the core mechanisms governing oxygen and nutrient delivery during exercise moves into the frame. That is not the same as saying VO₂max falls in athletes. It is saying that vascular responsiveness, which underlies exercise hyperemia and training adaptation, has become a biologically plausible target of exposure ^[19].

Wang extends the vascular concern in vitro by showing that nanoplastics suppress endothelial cell migration and promote inflammatory injury ^[69]. That matters because endothelial migration is a prerequisite for angiogenesis. Endurance adaptation is not only about the heart pumping harder or the mitochondria becoming more efficient. It is also about the body’s ability to remodel its vasculature in response to training. If endothelial migration is impaired, one possible downstream consequence is a less robust vascular adaptation to repeated aerobic work. That connection remains inferential, but it is not a trivial one ^[69].

Pulmonary function

The pulmonary literature develops a similarly plausible set of concerns, though again the leap to athlete-specific outcome data has not yet been made.

Michelini points to disruptions in both alveolar and bronchial systems, including reduced surfactant protein B and mucus overproduction ^[20]. Surfactant is not a minor detail. It is part of what allows alveoli to remain stable and efficient during gas exchange. A significant reduction in surfactant-related proteins suggests that microplastic exposure could, at least under some conditions, compromise the physical environment in which oxygen transfer takes place ^[20].

Breidenbach shows a five-fold increase in the neutrophil chemoattractant CCL3 and suppression of adaptive immune signaling in a 3D human airway epithelial model after aerosolized nanoplastic exposure ^[21]. That finding adds an inflammatory dimension to the pulmonary story. The issue is no longer just whether particles reach the lung. It is whether they reshape the immune tone of airway tissue in a direction that may impair resilience or recovery.

Gosselink’s work in primary bronchial epithelial cells from patients with chronic obstructive pulmonary disease cannot be mapped directly onto trained lungs, but it still helps define barrier vulnerability ^[22]. Cheng adds a fibroblast activation pathway, suggesting that nanoplastics may promote pulmonary fibrosis through iron-dependent mechanisms ^[23]. Kuttykattil brings the discussion to a more molecular level, reporting that ethylene terephthalate monomers derived from PET microplastics bind the beta-2 adrenergic receptor, the same receptor involved in bronchodilation during exercise ^[24]. That is not proof of impaired athletic breathing. But it is a striking reminder that plastics may intersect not only with lung tissue structure, but with receptor systems relevant to airway regulation.

The human pulmonary evidence remains limited but important. Zakynthinos detected microplastics in bronchoalveolar lavage fluid in five of eight patients undergoing diagnostic bronchoscopy, with 80% of particles below 50 micrometers, well within the respirable range ^[70]. Bardawil’s 2026 review helps situate those findings within the broader pulmonary literature, making clear that the lung is not only an exposure route but a plausible site of tissue-level consequence ^[71].

Taken together, these studies do not show that athletes have poorer lung function because of microplastics. They do show that the parts of the lung most relevant to gas exchange, airway integrity, and inflammatory control are increasingly part of the toxicological picture ^{[20-24,70,71]}.

Human cardiovascular evidence

The human cardiovascular literature is what prevents this section from being dismissed as purely theoretical.

Marfella’s New England Journal of Medicine paper remains the landmark study ^[25]. In 257 patients followed for a mean of 34 months after carotid endarterectomy, 58.4% had detectable polyethylene in their carotid plaques, and those patients experienced a 4.53-fold higher risk of myocardial infarction, stroke, or death ^[25]. That is not a subtle association. It is also not a causal proof. The study is observational, and the population already had established vascular disease.

Yang extends the signal by associating microplastics with elevated atherosclerotic risk and increased coronary lesion complexity in acute coronary syndrome patients, along with higher IL-6 and IL-12 in peripheral blood ^[26]. Cui adds paired-sample evidence suggesting that microplastic concentrations may be substantially higher in carotid plaques than in blood, supporting the idea of preferential vascular accumulation rather than simple passive circulation ^[72].

The broader review literature reinforces the seriousness of this domain. Prattichizzo, Goldsworthy, Wiewióra, Gu, Liu, Moorthy, Lee, Zhu, and Zhang all help establish cardiovascular biology as one of the most mature areas in the broader human-health discussion ^[27-35]. That does not mean the athlete question has been answered. It means the vascular question has become difficult to wave away.

The translational line, though, has to stay sharp. Diseased plaque in older patients is not the same biological context as healthy vascular tissue in trained athletes. The NEJM study cannot tell us whether microplastics are direct drivers of pathology, passive markers within inflamed tissue, or part of a more complex causal chain ^[25,53]. These studies establish relevance, access, and plausible disease association. They do not establish impaired exercise hyperemia, reduced threshold performance, or lower endurance capacity in healthy populations.

That is the right place to leave the section. The cardiovascular literature has raised the seriousness of the question. It has not finished answering it ^{[25-35,53,54]}.

Hormones under pressure: The particle-chemical distinction That matters

This is one of the easiest sections in the literature to overstate.

The broader field clearly supports concern about endocrine disruption in relation to plastics. What it does not support is collapsing every hormone-related finding into a single particle story. Some studies are about intact microplastics or nanoplastics. Some are about plastic-associated chemicals such as phthalates or BPA. Some likely reflect a mixture of both. That distinction matters, especially in athletic settings where exposure often comes through apparel, packaging, supplements, sweat, friction, and repeated contact with synthetic materials rather than through a single clean route. Bossio’s review is especially useful here because it keeps both endocrine biology and detection methodology in view, which helps prevent the section from becoming broader or more confident than the evidence allows ^[43].

Testosterone and reproductive biology

The clearest mechanistic evidence for endocrine disruption still comes from animal models.

Jin and Liu provide the core testosterone and reproductive-biology signal in the current reference set ^[44,45]. In Jin’s study, chronic polystyrene microplastic exposure over 180 days led to testicular bioaccumulation, with particles detected in germ cells, Sertoli cells, and Leydig cells, alongside significant reductions in serum testosterone, LH, and FSH. Mechanistically, the disruption traced through downregulation of the LHR/cAMP/PKA/StAR steroidogenic pathway, one of the central signaling routes through which testosterone synthesis is maintained ^[44].

Liu adds a related but more oxidative-stress-centered mechanism. In that model, microplastic exposure suppressed GPX1, increased oxidative stress, and accelerated testosterone decline through the PERK-EIF2α-ATF4-CHOP-SRD5A2 axis ^[45]. Read together, these studies suggest that the endocrine problem is not simply one of tissue irritation. It may involve direct interference with steroidogenesis, redox balance, and the intracellular machinery that supports hormone production.

In athletic physiology, that matters because testosterone and gonadotropin signaling sit close to a larger network of adaptation. They influence body composition, recovery, tissue repair, and training responsiveness. That does not mean the current literature proves that environmental microplastics are suppressing testosterone in athletes. But it does mean the reproductive endocrine axis is now part of the mechanistic map rather than an implausible side concern ^[44,45].

Human tissue detection

Human tissue detection is what raises the stakes.

Yu’s report of microplastics in 100% of 23 human testes examined, at a mean concentration of 328.44 μg/g, is not by itself a functional study ^[46]. It does not show endocrine dysfunction, impaired fertility, or altered training response. But it does establish access. Reproductive tissue is not outside the exposure story.

Zhao’s detection work in human testes and semen reinforces that point ^[47]. Taken together, these studies shift the conversation from abstract possibility to documented presence. That still falls short of proving hormonal effects in athletes, or even in the general population. But it removes the more comfortable assumption that reproductive tissues are too remote, too protected, or too physiologically separate to matter.

Human epidemiological signals

The epidemiological signal is real, but it has to be described precisely.

Large population datasets, especially NHANES-based analyses, show associations between urinary phthalate metabolites and lower testosterone, altered sex hormone ratios, lower lean body mass, and reduced grip strength ^[73-75]. Those findings are important because they suggest that plastic-associated exposure may already be intersecting with endocrine and performance-relevant biology at the population level.

But they also illustrate the central distinction of this section. These studies are tracking urinary metabolites of plasticizers, not physical microplastic particles. That means they should not be cited as direct evidence that intact particles themselves are driving the hormonal effect. They belong in the literature because they show that plastic-associated exposure can be endocrinologically meaningful. They do not resolve which part of that exposure mixture is doing the work.

That distinction is especially important in an athletic context, where real-world exposure may include food packaging, bottles, apparel, surface contact, and heated synthetic materials all at once. The epidemiology strengthens the concern. It does not isolate the mechanism ^[73-75].

Thyroid and growth hormone

The endocrine story is broader than testosterone.

Islam and colleagues found dose-dependent thyroid hormone disruption in mice exposed to polystyrene microplastics for 28 days, including substantial shifts in T4, TSH, thyroid-related gene expression, and histopathologic structure ^[76]. That matters because thyroid signaling governs basal metabolic rate, energy turnover, thermoregulation, and recovery capacity, all of which sit close to athletic performance even when they are not discussed in explicitly sports-specific terms.

The human thyroid literature is still early, but the signal is notable. In 1,250 mother-child pairs, Zhang and colleagues found that each quartile increase in cumulative placental microplastic exposure was associated with lower newborn T4 and TSH, with dose-response supported by Bayesian kernel machine regression ^[77]. That does not answer the athlete question directly. But it strengthens the broader endocrine case by showing that thyroid-related disruption is not confined to animal models alone.

Growth hormone signaling adds another layer. Zhang and colleagues separately reported that polystyrene microplastics induced a growth-hormone-resistance phenotype at the cellular level, blocking GH nuclear entry and downregulating JAK2-STAT1/3/5 signaling in human mesenchymal stem cells through ROS-induced senescence ^[78]. In practical terms, that finding matters because growth hormone biology sits upstream of tissue repair, cellular growth, and long-term adaptation. Again, this is mechanistic work, not performance data. But it widens the endocrine frame beyond reproductive hormones and suggests that plastics may intersect with several of the body’s major anabolic systems, not just one ^[76-78].

The caution

The main caution here is toxicological clarity.

Some endocrine effects may be driven by the physical particle itself. Some may be driven by plastic-associated chemicals such as phthalates or BPA. Some may reflect real-world mixtures in which the particle acts as carrier, surface, irritant, or co-exposure partner rather than the sole driver. In athletic life, that complexity becomes even harder to separate. Exposure may come through supplements, food packaging, bottles, synthetic surfaces, clothing, sweat, heat, and friction, often at the same time ^{[6,10,11,43-47,56,63]}.

That is why this section has to stay disciplined. The literature clearly justifies concern about endocrine disruption in relation to plastics and plastic-associated exposures. What it does not yet justify is a clean human claim that intact environmental microplastic particles are independently and directly suppressing hormones in athletes. The most credible formulation is narrower and stronger for being narrower: endocrine biology appears to be one of the systems at risk, but the relative contribution of particles, additives, and mixed exposure remains incompletely separated in humans ^{[6,10,11,43-47,56,63,73-78]}.

The gut as ground zero: Barrier, microbiome, and the muscle connection

The gut may be one of the most important interfaces in this entire discussion.

That is partly because ingestion is unavoidable. But it is also because the gut sits at the meeting point of exposure, immunity, nutrient handling, and systemic signaling. Athletes understand this intuitively, even if they do not usually describe it in toxicological language. The gut is where hydration meets barrier function, where micronutrient status meets inflammation, and where repeated stress is either absorbed well or amplified into something larger.

That makes it a particularly plausible site where microplastics could matter before any clear performance outcome is measured. A pollutant does not need to cause overt gastrointestinal disease to become relevant to athletes. It may be enough for it to make barrier function less stable, microbial balance less favorable, nutrient handling less efficient, or inflammatory signaling more persistent.

Microbiome and barrier integrity

Bora’s review is useful because it places microplastics inside the broader conversation around gut dysbiosis, barrier disruption, and chronic disease risk rather than treating them as an isolated toxin ^[48]. That framing is helpful because it matches how this literature is actually evolving. The gut story is not only about the presence of particles. It is about what happens when particles interact with the microbial and epithelial systems that help regulate inflammation, permeability, and metabolic signaling.

The experimental literature pushes that concern further. A 2024 Frontiers in Immunology paper shows that high-concentration oral polystyrene exposure can alter the intestinal environment and shift metabolic outcomes in mice ^[49]. Roh extends that logic beyond the intestine itself, showing downstream disruption in hepatic lipid, glucose, and amino acid metabolism ^[50]. That matters because it suggests gut exposure does not necessarily remain local. Once barrier integrity, immune activation, and metabolic signaling begin to shift, the consequences may become systemic.

Animal models now describe a fairly coherent pathway. Microplastics can alter gut microbiota composition, reduce short-chain fatty acid production, weaken tight junction integrity, increase permeability on FITC-dextran assays, and elevate circulating lipopolysaccharides, which then signal through TLR4 and NF-kB to promote systemic inflammation ^[79,80]. At that point, the gut is no longer just a site of contact. It becomes a source of inflammatory spillover.

One of the more important developments in this literature is that the gut-muscle axis is no longer only hypothetical. In mouse models, fecal microbiota transplant from microplastic-exposed donors to germ-free recipients partially reproduced muscle wasting, suggesting that gut dysbiosis itself can drive at least part of the downstream catabolic signal ^[79]. That is a meaningful step because it separates the story from simple direct particle toxicity and introduces a second mechanism: the microbiome as mediator.

For athletes, that possibility is especially relevant. If part of the downstream muscle signal begins in the gut, then performance biology may be affected not only through direct tissue exposure, but through altered microbial metabolites, inflammatory tone, and barrier integrity upstream.

Nutrient absorption

What makes this section especially relevant to athletic physiology is not just inflammation. It is the possibility of a chronic low-grade insult to nutrient handling.

Athletes depend on the gut not only for calories, but for usable biology: iron for oxygen transport, zinc for immune and repair processes, B vitamins for energy metabolism, amino acids for recovery, and a stable epithelial surface through which all of this has to move. A pollutant that perturbs the intestinal environment may therefore matter long before it produces obvious symptoms.

The current in vitro and animal literature suggests several possible routes. Microplastics have been reported to reduce iron transport, lower zinc uptake, adsorb vitamin B12 during digestion, and diminish brush border enzyme activity and absorptive surface area ^[81-83]. Those effects are not dramatic enough, on their own, to justify sweeping claims about deficiency in athletes. But they do point toward a biologically plausible problem: nutrient handling may become less efficient in ways that are subtle, cumulative, and easy to miss.

That is the kind of change that could matter in sport without announcing itself clearly. The athlete may not present with overt gastrointestinal illness. Instead, the signal may look like less stable energy regulation, noisier recovery, greater gut sensitivity under load, or a lower ceiling for adaptation over time. In that sense, nutrient absorption is not a side issue. It may be one of the most performance-relevant ways the gut literature connects back to training ^{[48-51,81-83]}.

The restraint here matters as much as the signal. The gut-muscle axis is mechanistically plausible and, in some models, compelling. But there is still no direct human evidence that environmental microplastic exposure slows glycogen repletion, prolongs soreness, or meaningfully blunts performance adaptation in athletes. This section matters because the biology is coherent enough to deserve sustained study, not because it has already been clinically settled ^{[48-51,53,79-83]}.

The paradox: Training increases exposure — and may also be the best defense

One reason this literature can feel conceptually slippery is that microplastic toxicity and exercise adaptation often speak in the same biological language.

Oxidative stress. Inflammatory signaling. Mitochondrial remodeling. AMPK activation. Nrf2 pathways. Endothelial responses. Immune shifts. These mechanisms appear across both domains. But they do not appear in the same form or for the same purpose. Exercise uses transient physiological stress as part of adaptation. It disrupts homeostasis in order to rebuild it at a higher level. Pollutant exposure is different. It may create low-grade, chronic, poorly timed stress that adds noise rather than useful signal.

That distinction matters. The question is not whether both exercise and microplastic exposure involve ROS or inflammation. The question is whether plastic-associated stress blunts, amplifies, or is neutralized by the normal adaptive choreography of training ^{[15-24,35-39,48-55]}.

Convergent and potentially synergistic stress

The oxidative and inflammatory signal from microplastic exposure is now well documented across experimental systems.

Nanoplastics activate NF-kB signaling, trigger NLRP3 inflammasome activity, and induce pro-inflammatory cytokine release including IL-6, TNF-alpha, and IL-1beta in macrophages and primary human immune cells, in some cases at concentrations described as environmentally relevant ^[84-86]. Chronic exposure also appears to erode antioxidant defenses. Across multiple tissues, studies report reductions in glutathione, superoxide dismutase, and glutathione peroxidase, a pattern that has been described as systemic antioxidant exhaustion rather than a brief, localized oxidative event ^[87].

That matters because training already relies on carefully timed oxidative and inflammatory signals. A hard session increases ROS. It perturbs the immune environment. It changes blood flow, mitochondrial signaling, and substrate use. Under normal conditions, those changes are part of the adaptive process. But if the background physiology is already carrying a chronic pollutant-linked oxidative burden, then the same workout may land in a different biological context. The stress is no longer purely training stress. It may be layered stress.

One animal study makes that possibility harder to ignore. In a model combining moderate exercise with nanoplastic exposure, the dual-exposed group showed IL-6 levels 1.8 times higher than predicted by simple addition, suggesting synergy rather than mere overlap ^[88]. In that same study, exercise-induced gut hypoperfusion appeared to enhance nanoplastic translocation across the gut barrier ^[88]. That does not prove the same thing happens in athletes. But it does sharpen the concept: under some conditions, exercise may not simply coexist with microplastic stress. It may magnify its biological consequences.

The exercise paradox

This is where the paradox becomes more interesting.

Exercise may increase exposure opportunity. Higher ventilation means more air and particles moving through the respiratory tract. More time on synthetic surfaces means more contact with dust, fibers, and degraded materials. Higher fluid intake means more contact with plastic packaging and bottled beverages. In exposure terms, training may open the door wider ^[5,6].

At the same time, exercise is one of the body’s most powerful resilience-building signals. It improves mitochondrial function, strengthens antioxidant defenses, alters inflammatory tone, and induces myokines that may help buffer injury. Lalruatmawii’s work points directly at that possibility. In rats, exercise and the myokine irisin ameliorated aspects of polyethylene microplastic-induced injury through PGC-1alpha, AMPK, Nrf2, and HO-1 related pathways, restoring hormone levels and improving histopathology ^[52]. That does not mean exercise “cancels out” microplastic exposure. It means the biology is more dynamic than a one-way harm model would suggest.

A 2026 human blood study in university students adds a provocative but still preliminary signal, reporting a correlation suggesting that regular exercise may reduce circulating microplastic and pollutant loads, possibly through enhanced metabolic clearance ^[55]. That finding needs to be handled carefully. Correlation is not mechanism, and the study does not establish how any clearance occurs. But it points in the same direction as the animal literature: training may simultaneously increase dose opportunity and increase biological resistance.

That is the paradox in its clearest form. Exercise may increase contact with environmental contaminants while also being one of the strongest available signals for maintaining mitochondrial, antioxidant, endocrine, and vascular resilience. The net result is not obvious in advance. It may depend on route, dose, polymer type, exposure timing, training status, recovery status, and the broader environment in which exercise occurs.

The human signal

The human literature is still early enough that mixed signals should be expected.

Xiao’s pilot study is useful precisely because it looks like an early field finding rather than a clean conclusion ^[53]. In 16 male college students, fecal microplastic burden was associated with oxidative damage biomarkers, including MDA, a marker of lipid peroxidation, and 8-OHdG, a marker of oxidative DNA damage ^[53]. But the same study did not show clear lung function or blood pressure deficits in that small sample ^[53].

That pattern is instructive. Internal exposure may be measurable. Oxidative signatures may be visible. Obvious functional outcomes may still remain below the threshold of detection, especially in small cohorts, healthy young subjects, or studies not designed around performance endpoints.

The particle details matter too. In Xiao’s data, fibrous particles and specific polymers, especially polyethylene and polyamide, were the main drivers of the oxidative-damage signal ^[53]. That is particularly relevant in an athletic context, where synthetic apparel and textile shedding are plausible contributors to inhaled or contact-associated fiber exposure. It suggests that not all particles should be treated as biologically interchangeable. Shape and polymer type may matter, and fibers may deserve special attention in sports settings.

This is the section where overstatement is most tempting and least justified. It would be easy to say that microplastics increase oxidative stress and therefore must impair training adaptation. The literature does not support that leap. What it supports is more nuanced, and in some ways more interesting: exercise may increase exposure while also activating counter-regulatory pathways that help limit damage. The final outcome probably depends on route, dose, particle type, training status, environmental context, and timescale ^{[5,6,15-24,36-39,48-55,84-88]}.

That is not a weak conclusion. It is the honest one.

Inside the body: What human studies have actually found

At this point, the human evidence establishes three things.

First, internal exposure is real. Microplastics and nanoplastics are no longer theoretical contaminants sitting somewhere outside the body. They are being detected in human tissues and biological fluids across a growing number of compartments. Leslie and colleagues reported microplastics in 77% of human blood samples ^[89]. Jenner found them in 11 of 13 human lung tissue samples ^[90]. Ragusa documented them in human placenta ^[91]. Horvatits found them in all 30 cirrhotic liver samples examined ^[92]. A 2026 study reported detectable microplastics in 83% of university student blood samples ^[55]. As discussed earlier, they have also now been identified in human testes ^[46,47], arterial plaques ^[25,26,72], and musculoskeletal tissues including skeletal muscle and bone ^[68].

That does not settle toxicity. Detection is not the same thing as dysfunction. But it does settle access. The question is no longer whether these particles can enter the body. It is what that presence means across different tissues, over different time scales, and under different exposure conditions.

Second, human disease relevance is no longer hypothetical, especially in cardiovascular biology. Marfella and Yang do not prove causality, but together they make it difficult to argue that plastic-associated biology remains only a speculative environmental concern ^[25,26]. The literature has also begun to move beyond tissue detection toward systemic inflammatory relevance, including published epidemiological evidence linking estimated microplastic exposure with higher hs-CRP, IL-6, and fibrinogen ^[93]. In other words, the field is beginning to connect exposure not only to presence, but to physiology.

Third, the athlete question remains largely unanswered. There are still no athlete biomonitoring cohorts tied to measured performance outcomes. There are no direct comparisons across sport types, training environments, or seasonal exposure patterns. There are no threshold studies telling us how much inhaled or ingested burden begins to matter for vascular responsiveness, pulmonary function under exertion, lactate threshold, or repeat sprint performance ^[5,6,53].

That leaves the human literature in an unusual position. It is stronger than dismissal would suggest, and still thinner than certainty would require. The most accurate summary is neither alarmist nor casual. The field now has enough human relevance to demand seriousness, and still not enough athlete-specific endpoint data to support sweeping claims about impaired performance ^{[5,6,25-35,53]}.

Where the science still falls short

A technical deep dive should say plainly where the literature still fails.

The first problem is translation. Many of the most detailed mechanistic studies rely on pristine polystyrene, tightly defined particle sizes, and experimental doses that do not cleanly resemble the mixed, weathered, additive-laden particles encountered in real athletic environments ^{[4,10-12,15-24,36-45,54,56]}. In actual sport settings, exposure is unlikely to arrive as one clean polymer in one clean form. It is more likely to involve fibers from apparel, degraded tire and turf fragments, packaging-derived particles, indoor dust, and particles carrying co-pollutants or additives. Polymer type, size, shape, weathering history, and chemical cargo can all alter biological behavior. A smooth commercial bead is not the same thing as a tire-wear fragment or a fiber shed from synthetic clothing.

That mismatch matters because it shapes how confidently mechanistic findings can be applied to real athletes. It matters even more because when researchers examine actual human tissues, polystyrene is often not the dominant polymer. Polyethylene, polypropylene, and PVC appear more frequently in several human datasets ^{[25,46,55,72,89]}. So the experimental literature is valuable, but not perfectly representative.

The second problem is endpoint scarcity. The literature has still not caught up to the questions athletes would most reasonably ask. No one has shown whether environmental exposure alters interval recovery, lactate handling, threshold physiology, adaptation across a training block, or susceptibility to overreaching ^[5,6,53]. No one has measured whether athletes in higher-exposure settings, such as indoor facilities, synthetic turf sports, or high-supplement use populations, carry a different burden or perform differently over time. The biological scaffolding is there. The direct performance bridge is not.

The third problem is toxicological ambiguity. Endocrine disruption is where this becomes most obvious, but the issue is broader than hormones alone. The literature often discusses particle effects and additive effects as though they were interchangeable. They are not. In real environments they may coexist, and they may amplify one another, but that does not mean they should be treated as one undifferentiated mechanism ^{[6,10,11,43-47,56]}. A BPA-rich fabric, a phthalate-containing package, and an intact microplastic particle may all matter. They do not necessarily matter in the same way.

The fourth problem is contradiction. Exercise may increase intake while also increasing resilience. The accumulation hypothesis and the clearance hypothesis do not describe the same biology. One is largely about dose opportunity. The other is about retention, metabolism, and excretion. Right now, the field has not fully reconciled them ^{[5,6,52,53,55]}. The contradictions do not stop there. Some studies report weight gain after exposure, others weight loss or no clear effect. Some suggest smaller particles are more concerning because of penetration and reactivity, while others report larger particles producing greater structural damage, likely through different mechanisms ^[94].

That does not mean the literature is unreliable. It means it is still immature. Training status, gut microbiome composition, baseline diet, particle characteristics, co-exposures, and timing may all change the outcome. The athlete is not simply a passive recipient of burden. Training itself may alter how the body handles damage, adaptation, clearance, and repair ^[5,6,52,53].

So the right stance here is provisional, not dismissive. The contradictions are not a reason to walk away from the topic. They are a sign that the field is finally becoming specific enough to ask harder questions.

Not settled, not empty. Just early

The current literature does not prove that environmental microplastics measurably impair athletic performance in humans.

It does, however, support a stronger statement than was possible even a few years ago. Athletes live in exposure settings that are distinctive and repeated. Human tissue-detection and cardiovascular studies show that internal relevance is real. Muscle, vascular, pulmonary, endocrine, and gut studies now outline multiple biologically plausible routes by which microplastics and nanoplastics could interfere with training, recovery, and adaptation.

That is why the most credible conclusion is not certainty. It is seriousness without theatrics.

Microplastics no longer look like a fringe concern sitting outside performance biology. They look more like an emerging stressor moving through systems athletes depend on most, including oxygen delivery, metabolic control, barrier integrity, endocrine signaling, and tissue repair. What remains missing is not reason for concern. It is the direct athlete evidence needed to measure how much these mechanisms matter in the real world.

That is where the literature stands now. Not settled. Not empty. Just early, and increasingly difficult to ignore.